Evidence map›Paper›PMID 32613110›Full record

ArticleHeliyon2020

Monitoring pharmaceuticals and personal care products in water and fish from the Gulf of Urabá, Colombia.

Diana Pemberthy M, Yisela Padilla, Andrés Echeverri, Gustavo A Peñuela

Abstract read
In one paragraph

Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Diana Pemberthy MUniversity of Antioquia, Faculty of Engineering, University Research Headquarters (SIU), GDCON Group, Street 70 No 52 -21, Medellín, Colombia.
Yisela PadillaUniversity of Antioquia, Faculty of Engineering, University Research Headquarters (SIU), GDCON Group, Street 70 No 52 -21, Medellín, Colombia.
Andrés EcheverriUniversity of Antioquia, Faculty of Engineering, Apartadó (Antioquia), Colombia.
Gustavo A PeñuelaUniversity of Antioquia, Faculty of Engineering, University Research Headquarters (SIU), GDCON Group, Street 70 No 52 -21, Medellín, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gulf of Urabá is considered a tourist zone of Antioquia Department attracts a large number of visitors to explore the aquatic ecosystem and beaches thus offering a large economic benefit. However, this region has been affected by various anthropogenic effects thus generating an environmental problematic that affect aquatic ecosystem. Over the years, several research has been evaluated pollutant such as pesticides, metals and physicochemical parameters, even our laboratory had found several toxic metals in fish from this same area. The presence of emerging pollutant in matrices such as seawater and fish from Gulf of Urabá have not been reported, and to the best of our knowledge, this is the first study. This work presents important aspects relating to sampling, monitoring and surveillance of seawater and several fish species caught in the area in order to determinate the content of emerging pollutant (triclosan, ibuprofen, diclofenac) using UPLC-QqQ/MS. In general, all three pharmaceuticals in different sampling sites were detected and total concentrations ranged from 0.10 to 1.54 μg/L in surface water. However, emerging pollutants content in fish muscle was not detected. In addition, a high variability in triclosan, ibuprofen and diclofenac concentrations according to the season of sampling was found. Regarding to seasonal variations, most emerging pollutant in the surface water had variation in levels both dry and wet season. Better removal was presented in the dry season, due to stronger irradiation and greater activity of microorganisms.

Indexed as

ChemistryEmerging pollutantsEnvironmental scienceFishFood scienceGulf of UrabáPersonal care productsPharmaceutical chemistryPharmaceutical sciencePharmaceuticals productsSeawaterUPLC-QqQ/MS

Identifiers

PMID32613110
PMCPMC7317696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.